The drug is significant because it is the first non-steroidal therapy for the skin condition in more than 15 years. Pfizer acquired the Eucrisa (crisaborole) when it bought its developer, Anacor ...

While some folks find great treatments and over-the-counter products that work well for their skin, others need prescription ...

When it comes to eczema, carrier oils can help to soothe dry and irritated skin, reduce inflammation, and improve overall skin health. When choosing best carrier oil for eczema, it is essential to ...

Thankfully, scientists are now in the process of developing new non-steroidal ointments and even an injectable drug called Dupilumab for the most extreme cases, so the future for eczema sufferers ...

Dermatology specialist LEO Pharma has built the case for its first-in-class chronic hand eczema (CHE) drug delgocitinib, saying it outperformed the only approved drug therapy for the condition in ...

I was and am able to manage my flare-ups with products that are designed for those with eczema prone skin – check out some of the best options below. Just like most of their products ...

Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a mid-stage trial, the company ...

The clinical trial is for a new drug for people with moderate to severe eczema, the NHS trust says The first UK patient has been recruited to take part in a clinical trial for a new drug for ...

Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab said on Wednesday it would end the development of its eczema drug after it failed to meet the main and secondary goals of a mid-stage trial.